People enrolled in early stage trials for possible cancer treatments may underestimate the risks involved and overestimate the potential benefits, suggests a new study.
Papildomos nuorodos
Cancer trial participants may have misconceptions
Šis įrašas paskelbtas Biomedicininių tyrimų etika kategorijose.
